Neuro-ophthalmological optic nerve cupping: an overview
E Waisberg, JA Micieli - Eye and brain, 2021 - Taylor & Francis
Optic nerve cupping or enlargement of the cup-to-disc ratio is widely recognized as a feature
of glaucoma, however it may also occur in non-glaucomatous optic neuropathies. The most …
of glaucoma, however it may also occur in non-glaucomatous optic neuropathies. The most …
[HTML][HTML] New insights into the role of autophagy in retinal and eye diseases
B Villarejo-Zori, JI Jiménez-Loygorri… - Molecular Aspects of …, 2021 - Elsevier
Autophagy is a fundamental homeostatic pathway that mediates the degradation and
recycling of intracellular components. It serves as a key quality control mechanism …
recycling of intracellular components. It serves as a key quality control mechanism …
Toxic optic neuropathy
P Sharma, R Sharma - Indian journal of ophthalmology, 2011 - journals.lww.com
Toxic optic neuropathy : Indian Journal of Ophthalmology Toxic optic neuropathy : Indian
Journal of Ophthalmology Log in or Register Get new issue alertsGet alerts Submit a …
Journal of Ophthalmology Log in or Register Get new issue alertsGet alerts Submit a …
[HTML][HTML] Epidemiologic and clinical characteristics of optic neuritis in Japan
H Ishikawa, T Kezuka, K Shikishima, A Yamagami… - Ophthalmology, 2019 - Elsevier
Purpose To elucidate the clinical and epidemiologic characteristics of optic neuritis in Japan.
Design Multicenter cross-sectional, observational cohort study. Participants A total of 531 …
Design Multicenter cross-sectional, observational cohort study. Participants A total of 531 …
Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases
DA Srinivasarao, G Lohiya… - Wiley Interdisciplinary …, 2019 - Wiley Online Library
The eye consists of sensitive, compactly adjoined tissue structures which act as strong
physical (static) and physiological (dynamic) barriers that prevent entry of foreign bodies into …
physical (static) and physiological (dynamic) barriers that prevent entry of foreign bodies into …
Magnetic resonance imaging of optic nerve
F Gala - Indian Journal of Radiology and Imaging, 2015 - thieme-connect.com
Optic nerves are the second pair of cranial nerves and are unique as they represent an
extension of the central nervous system. Apart from clinical and ophthalmoscopic evaluation …
extension of the central nervous system. Apart from clinical and ophthalmoscopic evaluation …
Pathogenesis, clinical features, and treatment of patients with myelin oligodendrocyte glycoprotein (MOG) autoantibody-associated disorders focusing on optic neuritis …
K Tanaka, T Kezuka, H Ishikawa, M Tanaka… - International Journal of …, 2023 - mdpi.com
Although there is a substantial amount of data on the clinical characteristics, diagnostic
criteria, and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) autoantibody …
criteria, and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) autoantibody …
[HTML][HTML] Design, optimization, and in vitro characterization of idebenone-loaded PLGA microspheres for LHON treatment
R Varela-Fernández, C Bendicho-Lavilla… - International Journal of …, 2022 - Elsevier
Biodegradable poly (lactic-co-glycolic acid) microspheres (PLGA MSs) are attractive delivery
systems for site-specific maintained release of therapeutic active substances into the …
systems for site-specific maintained release of therapeutic active substances into the …
Smoking and eye pathologies. A systemic review. Part II. Retina diseases, uveitis, optic neuropathies, thyroid-associated orbitopathy
MŦ Nita, A Grzybowski - Current pharmaceutical design, 2017 - ingentaconnect.com
Background: Tobacco smoking has detrimental influence on human health. Aim: The
analysis of influence of tobacco smoking on retina diseases, uveitis, optic neuropathies, and …
analysis of influence of tobacco smoking on retina diseases, uveitis, optic neuropathies, and …
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
AT Wilmes, S Reinehr, S Kühn, X Pedreiturria… - Journal of …, 2018 - Springer
Background The oral immunomodulatory agent laquinimod is currently evaluated for
multiple sclerosis (MS) treatment. Phase II and III studies demonstrated a reduction of …
multiple sclerosis (MS) treatment. Phase II and III studies demonstrated a reduction of …